Garcia Michael C, Surampudi Vijaya, Li Zhaoping, Saggar Rajan, Shah Sapna
Center for Human Nutrition, Division of Clinical Nutrition, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Respir Med Case Rep. 2020 Aug 18;31:101193. doi: 10.1016/j.rmcr.2020.101193. eCollection 2020.
A 47-year-old male with morbid obesity and progressive pulmonary fibrosis was admitted to the intensive care unit (ICU) with worsening hypoxia and nocturnal ventilator dependence. Due to a significant oxygen requirement, the patient could only safely remain in an acute care setting. Unfortunately, he was not eligible for lung transplantation due to having obesity, a relative contraindication to lung transplantation due to potential for post transplantation complications and increased mortality. Therefore, we treated the patient with a modified very low calorie diet (MVLCD) to achieve weight loss. He had successful, sustained weight loss over a period of seven weeks and reached a target weight that made him eligible for transplantation. He subsequently underwent successful bilateral lung transplantation. The patient had improved metabolic parameters and no side effects attributable to the reduced calorie diet. This report shows that in patients with end stage lung disease and a poor prognosis without transplantation, inpatient weight loss is safe and may allow for potentially lifesaving lung transplantation.
一名47岁男性,患有病态肥胖和进行性肺纤维化,因缺氧加重和夜间依赖呼吸机而入住重症监护病房(ICU)。由于对氧气的需求量很大,患者只能安全地留在急症护理环境中。不幸的是,由于肥胖,他不符合肺移植条件,肥胖是肺移植的相对禁忌症,因为可能会出现移植后并发症并增加死亡率。因此,我们采用改良极低热量饮食(MVLCD)对患者进行治疗以实现体重减轻。他在七周的时间里成功且持续地减轻了体重,达到了使他符合移植条件的目标体重。随后,他成功接受了双侧肺移植。患者的代谢参数得到改善,且未出现因低热量饮食导致的副作用。本报告表明,对于终末期肺病且不进行移植预后较差的患者,住院期间体重减轻是安全的,并且可能使挽救生命的肺移植成为可能。